Gercel-Taylor C - Search Results

1

Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences.

Sabapatha A, Gercel-Taylor C, Taylor DD. Sabapatha A, et al. Am J Reprod Immunol. 2006 Nov-Dec;56(5-6):345-55. doi: 10.1111/j.1600-0897.2006.00435.x. Am J Reprod Immunol. 2006. PMID: 17076679

2

Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss.

Saunders RD, Nakajima ST, Rai SN, Pan J, Gercel-Taylor C, Taylor DD. Saunders RD, et al. Among authors: gercel taylor c. Am J Reprod Immunol. 2012 Nov;68(5):438-49. doi: 10.1111/j.1600-0897.2012.01182.x. Epub 2012 Aug 31. Am J Reprod Immunol. 2012. PMID: 22935024

3

Genistein reverses diminished T-cell signal transduction, induced by post-menopausal estrogen levels.

Parry JP, Taylor DD, Nakajima ST, Gercel-Taylor C. Parry JP, et al. Am J Reprod Immunol. 2009 Jan;61(1):26-33. doi: 10.1111/j.1600-0897.2008.00658.x. Am J Reprod Immunol. 2009. PMID: 19086989

4

Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels.

Ku LT, Gercel-Taylor C, Nakajima ST, Taylor DD. Ku LT, et al. Immun Ageing. 2009 Mar 5;6:1. doi: 10.1186/1742-4933-6-1. Immun Ageing. 2009. PMID: 19265538 Free PMC article.

5

Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients.

Taylor DD, Edwards RP, Case CR, Gerçel-Taylor C. Taylor DD, et al. Gynecol Oncol. 2004 Jul;94(1):54-60. doi: 10.1016/j.ygyno.2004.03.032. Gynecol Oncol. 2004. PMID: 15262119 Clinical Trial.

6

Exosomal microRNA: a diagnostic marker for lung cancer.

Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Rabinowits G, et al. Clin Lung Cancer. 2009 Jan;10(1):42-6. doi: 10.3816/CLC.2009.n.006. Clin Lung Cancer. 2009. PMID: 19289371

7

T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.

Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL. Taylor DD, et al. Clin Cancer Res. 2003 Nov 1;9(14):5113-9. Clin Cancer Res. 2003. PMID: 14613988

8

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Taylor DD, Gercel-Taylor C. Taylor DD, et al. Among authors: gercel taylor c. Semin Immunopathol. 2011 Sep;33(5):441-54. doi: 10.1007/s00281-010-0234-8. Epub 2011 Jun 19. Semin Immunopathol. 2011. PMID: 21688197 Review.

9

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.

Taylor DD, Gercel-Taylor C, Parker LP. Taylor DD, et al. Gynecol Oncol. 2009 Oct;115(1):112-120. doi: 10.1016/j.ygyno.2009.06.031. Epub 2009 Jul 31. Gynecol Oncol. 2009. PMID: 19647308 Free PMC article.

10

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Taylor DD, Gercel-Taylor C. Taylor DD, et al. Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Gynecol Oncol. 2008. PMID: 18589210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results